Mark Anderson
Welcoming you to another chapter of our start-up spotlight series. Based in the city known for its world-leading university and vibrant entrepreneurial ecosystem, we are turning our focus this time to Oxford, the UK’s cradle of biotech innovation. From AgTech to Artificial Intelligence, sustainable manufacturing to disease diagnostics, these Oxford-born companies define technology advancement in the fight against global challenges.
We will get to know these start-ups that were founded in 2020 and beyond. Each born from the mix of enterprise and academia, they represent the future of the rapidly expanding field of biotechnology and the expanding possibilities that come with it.
Let’s take a plunge into the captivating world of these innovative teams and the solutions they bring to the fore in the biotech sphere through this virtual tour of Oxford’s biotech startup landscape.
Kyomei
Based in Oxford, Kyomei is revolutionizing the agriculture industry by developing a meat protein production system using plant cell biology. Their approach uses sustainable methods to add flavor to meat-based alternatives. Founded in 2021, Kyomei is making waves in the AgTech, Biotechnology, Organic Food, and Sustainability industries.
coding.bio
With a focus on Artificial Intelligence, Biotechnology, Life Science, Machine Learning, and Therapeutics, coding.bio is based out of Oxford. Simon Bornschein is one of the renowned founders of this company.
Etcembly
Working in Biotechnology and Machine Learning, Etcembly is developing the world’s largest machine learning database combined with profound immunology expertise to deliver the most safe and powerful TCR immunotherapies through rapid computer-assisted engineering.
Oxford Silk Phage Technologies
Oxford Silk Phage Technologies, founded by James Gilbert and Stephanie Lesage, provide antibacterial biomaterial technology that combines silk with bacteriophages to battle the escalating problem of surgical implant and wound infections.
MetaGuideX
MetaGuideX is an Oxford based startup operating in the Biotechnology, Health Care, Health Diagnostics, and Life Science industry.
HydRegen
Providing sustainable solutions for chemical manufacturing is HydRegen, a biotechnology company established in 2020 and based in Oxford, United Kingdom.
Nanolyse Technologies
Working across Agriculture, Biotechnology, Chemical, Nanotechnology, Sensor, and Water, Nanolyse Technologies was founded in 2020 by Dr. Imad Ahmed, an academic from the prestigious Oxford University. Dr. Graham Hine, a successful technology entrepreneur, is the company Director.
T-Cypher Bio
T-Cypher Bio, an early-stage biotechnology company, aims to revolutionize the treatment of solid tumors, autoimmune, inflammatory, and infectious diseases by overcoming challenges in the identification of therapeutically relevant targets and TCRs.
Accession Therapeutics
The team at Accession Therapeutics, led by Bent Jakobsen, PhD FMedSci, is developing a range of products to the early clinical trial stage which have the potential to treat some of the most intractable and widespread forms of cancer.
Alethiomics
Under the leadership of founders Adam Mead and Bethan Psaila, Alethiomics harnesses the power of single cell multi-omic technology to discover and develop treatments for patients with blood cancer.
OxVax
OXvax Ltd works on the development of an advanced next-generation dendritic cell vaccine platform, focused on the treatment of solid tumor cancers. This spin-out company from the University of Oxford is founded by Marcelo Bravo.
